Синдром диссеминированного внутрисосудистого свертывания крови - Макацария А.Д.
ISBN 5-8249-0078-7
Скачать (прямая ссылка):
196. Bussen S, Schwarzmann G, Steck T: Clinical aspects and therapy of amniotic fluid embolism. Illustration based on a case report. Z Geburtshilfe Neonatol 201:95,1997
197. Cafagna D, Ponte E: Pulmonary embolism of paraneoplastic origin. Minerva Med 88:523, 1997
• 198. Ceriello A, Giacomello R, Colatutto A, et al: Increased prothrombin fragment 1 + 2 in Type I diabetic patients. IIaemostasis 22:50, 1992
199. Cheung DK, JH Raaf: Selection of patients with malignant ascites for a peritoneovenous shunt. Cancer 50:1204, 1982
200. Cincotta R, Ross A: A review of eclampsia in Melbourne: 1978-1992. Australian & New Zealand Journal of Obstetrics and Gynaecology. 36:264, 1996
201. Clavin SA, JL Bobbitt, RT Shuman, et al: Use of peptidyl-4-meth-oxy-2-naphthylamides to assay plasmin. Anal Biochem 80:355, 1977
202. Collen P: Identification and some properties of a new fast-acting plasmin inhibitor in human plasma. Eur ) Biochem 69:209, 1976
203. Collins P, Noble K, Reittie J, et al: Induction of tumor factor expression in human monocyte/endothelium cocultures. Br ] Haematol 91:963,1995
204. Colman RW, Robboy SJ, Minna JD. DIC: an approach. AmJ Med 1972; 52:679
205. Corrigan JJ: Changes in the blood coagulation system associated with septicemia. N Engl ] Med 279:851, 1968
206. Cortney LD: Amniotic fluid embolism. Obstet Gynecol Surv 29:169, 1974
207. CronbergS, Skansberg P, Nivenios-Larsson K: Disseminated intravascular coagulation in septicemia caused by beta-hemolytic streptococci. Thromb Res 3:405,1973
487
208. Cronlund MJ Hardin, J Burton, et al: Fibrinopeptide-A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus ervthematosis. J Clin Invest 58:142,1976
209. D'Addato F, Repinto A, Angeli G: Amniotic fluid embolism in trial of labor A case report. Minerva Ginecol 49:217,1997
210. D'Anna R: The HELLP syndrome. Notes on its pathogenesis and treatment. Minerva Ginecol 48:147,1996
211. Davies S: Amniotic fluid embolism and isolated disseminated intravascular coagula tion. Can J Anaesth 46:456, 1999
212. Debette M, Samuel D, Ichai P, et al: Labor complications of the HELLP syndrome without any predictive factors. Gastroenterol Clin Biol 23:264, 1999
213. Demers C, Ginsberg JS, Henderson P, et al: Measurements of markers of activated coagulation in antithrombin 111 deficient patients. Thromb Haemost 67:542, IS'92
214. Douglas JT, Shah M, Lowe GDO, et al: Fibrinopeptide-A and beta-thromboglobulin levels in preeclampsia and hypertensive pregnancy. Thromb Haemost 46:8,1981
215. Eckhardt T, Muller-Berghous G: The role of blood platelets in the precipitation of soluble fibrin endotoxin. Scandanavian Journal of Haematology 14:181, 1975
216. Ellis DR, Eaton AS, Plank MC, et al: A comparative evaluation of ELIS As for D-dimer and related fibrin(ogen) degradation products. Blood Coagul Fibrinolysis 4:537,1993
217. Elms MJ, IH Bunce, PG Bundesen, et al: Measurement of cross-linked fibrin degradation products - an immunoassay using monoclonal antibodies. Thromb Haemost 50:591, 1983
218. Elsayed Y, Nakagawa K, Ichikawa K, et al: Expression of tissue factor and interleukin-1 beta in a novel rabbit model of disseminated intravascular coagulation induced by carrageenan and lipo-polysaccharide. Pathobiology 63:328, 1995
219. English CJ, Roller L, Burslem RVV: A study of the procoaguiant properties of amniotic fluid and their correlation with the lecithin/ sphingomyelin ratio. BrJ Obstet Gynaecol 88:133, 1981
220. Fareed J, Віск RL, Hoppenstedt D, et al: Molecular markers of hemostatic activation: Implications in the diagnosis of thrombosis, vascular and cardiovascular disorders. Clin Lab Med 15:39,1995
221. Fareed J, HL Messmore, JM Walenga, et al: Laboratory evaluation of antithrombin III: A critical overview of currently available methods for antithrombin 111 measurements. Semin Thromb Hemost 8:288, 1982
222. Feinstein D: Treatment of disseminated intravascular coagulation. Semin Thromb Hemostas 14:351, 1988
488
223. Foa P1 Pellacani P. SuI fermento fibrmogeno: sulle azioni tossiche, escercitate da alcuni organi freschi. Arch Sei Med (Torino) 1884; 7:113.
224. Frances RB. Acquired purpura fulminans Semin Thromb Hemost 1990; 16:310
225. Frenkel UP, Віск RL: Issues of thrombosis and hemorrhagic events in patients with cancer. Anticancer Res 18:1-4,1998
226. Gando S, Kameue T, Nanzaki S, et al: Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory re sponse syndrome. Thromb Res 80:519, 1995
227. Gando S, Nakanishi Y, Tedo I: Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction. Crit Care Med 23:1835,1995
228. Gilbert WM, Danielsen B: Amniotic fluid embolism: Decreased mortality in a population-based study. Obstet Gynecol 93:973,1999
